Patient Satisfaction

0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Teva
TevaIsrael - Petach Tikva
1 program
Budesonide, Formoterol Fumarate DihydrateN/A1 trial
Active Trials
NCT02384577Completed4,034Est. Sep 2016
Hyperfine
HyperfineCT - Guilford
1 program
Swoop Plus Mk2.0N/A1 trial
Active Trials
NCT06930534RecruitingEst. Apr 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
HyperfineSwoop Plus Mk2.0
TevaBudesonide, Formoterol Fumarate Dihydrate

Clinical Trials (2)

Total enrollment: 4,034 patients across 2 trials

NCT06930534HyperfineSwoop Plus Mk2.0

Portable Rapid Imaging for Medical Emergencies

Start: Apr 2025Est. completion: Apr 2026
N/ARecruiting
NCT02384577TevaBudesonide, Formoterol Fumarate Dihydrate

Study to Evaluate Satisfaction and Usability of DuoResp® SPIROMAX® in Asthma and COPD Treatment

Start: Jul 2014Est. completion: Sep 20164,034 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 4,034 patients
2 companies competing in this space